OCT-Angiography for monitoring and managing neovascular age-related macular degeneration

被引:22
|
作者
Malamos, P. [1 ]
Tsolkas, G. [1 ]
Kanakis, M. [2 ]
Mylonas, G. [3 ]
Karatzenis, D. [1 ]
Oikonomopoulos, N. [1 ]
Lakoumentas, J. [4 ]
Georgalas, Ilias [2 ]
机构
[1] Ypapanti Eye Clin, Retina & Macula Serv, Athens, Greece
[2] Univ Athens, G Genimatas Gen Hosp Athens, Univ Eye Clin 1, Med Sch, Athens, Greece
[3] Acad Teaching Hosp St John God, Dept Ophthalmol, Vienna, Austria
[4] Univ Patras, Sch Med, Dept Med Phys, Rion, Greece
关键词
OCT Angiography; OCT-A; neovascular AMD; monitoring; treatment; OPTICAL COHERENCE TOMOGRAPHY; AMPLITUDE-DECORRELATION ANGIOGRAPHY; CHOROIDAL NEOVASCULARIZATION; FLUORESCEIN ANGIOGRAPHY;
D O I
10.1080/02713683.2017.1356336
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the combined use of optical coherence tomography and angiography (OCT-A) for imaging choroidal neovascularization (CNV) secondary to neovascular age-related macular degeneration (nAMD). Materials and Methods: This prospective observational study was conducted from May 2015 to April 2017. Included in the study were 54 patients (n = 63 eyes), all of whom had CNV secondary to nAMD and all of whom had been examined by OCT-A. Angioscans (3x3 and 6 x 6) and conventional B-scan OCT scans were obtained for all patients at baseline and at various times during the 24-month follow-up period. For diagnostic confirmation, conventional imaging methods fluorescein angiography (FA) and indocyanine green angiography (ICGA) were performed at baseline. A total of 13 patients (n = 15 eyes) underwent serial imaging during 34 follow-up visits. The main outcomes included (i) determination of OCT-A sensitivity for the detection of CNV (classic and occult) and (ii) the correlation between B-scan OCT and OCT-A vis-a-vis consecutive follow-up changes. Results: At baseline, the detection rate (i.e., overall sensitivity) of OCT-A for detecting CNV was 64.4% (75.7 and 48.0% for classic and occult CNV, respectively), independent of prior treatment status. In terms of quality, 6 x 6 angioscans were superior to 3 x 3. Moreover, specific CNV morphologic patterns by B-scan OCT did not correlate with lesion composition. Correspondence between OCT-A and B-scan OCT was observed in only 53% of the cases. Conclusions: OCT-A may prove to be a valuable adjunctive diagnostic tool for the interpretation of CNV, as it not only reduces the need for invasive angiographic procedures but also facilitates the follow-up process.
引用
收藏
页码:1689 / 1697
页数:9
相关论文
共 50 条
  • [21] Assessment of Exudative Activity of Choroidal Neovascularization in Age-Related Macular Degeneration by OCT Angiography
    von der Emde, Leon
    Thiele, Sarah
    Pfau, Maximilian
    Nadal, Jennifer
    Meyer, Johanna
    Moeller, Philipp T.
    Schmid, Matthias
    Fleckenstein, Monika
    Holz, Frank G.
    Schmitz-Valckenberg, Steffen
    OPHTHALMOLOGICA, 2020, 243 (02) : 120 - 128
  • [22] Ranibizumab in neovascular age-related macular degeneration
    Eng, Kenneth T.
    Kertes, Peter J.
    CLINICAL INTERVENTIONS IN AGING, 2006, 1 (04) : 451 - 466
  • [23] Optical Coherence Tomography for the Monitoring of Neovascular Age-Related Macular Degeneration A Systematic Review
    Castillo, Mayret M.
    Mowatt, Graham
    Elders, Andrew
    Lois, Noemi
    Fraser, Cynthia
    Hernandez, Rodolfo
    Amoaku, Winfried
    Burr, Jennifer M.
    Lotery, Andrew
    Ramsay, Craig R.
    Azuara-Blanco, Augusto
    OPHTHALMOLOGY, 2015, 122 (02) : 399 - 406
  • [24] Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration
    Heier, Jeffrey S.
    Liu, Yingna
    Holekamp, Nancy M.
    Ali, Mohsin H.
    Astafurov, Konstantin
    Blinder, Kevin J.
    Busquets, Miguel A.
    Chica, Moises A.
    Elman, Michael J.
    Fein, Jordana G.
    Hahn, Paul
    London, Nikolas
    Margolis, Thomas
    Modi, Yasha S.
    Rachitskaya, Aleksandra
    Schneider, Eric W.
    Stoller, Glenn L.
    Wang, Jay C.
    Shah, Ankoor R.
    JOURNAL OF VITREORETINAL DISEASES, 2025, 9 (02) : 158 - 165
  • [25] The Diagnostic Capability of Swept Source OCT Angiography in Treatment-Naive Exudative Neovascular Age-Related Macular Degeneration
    Ahmed, Daniel
    Stattin, Martin
    Haas, Anna-Maria
    Kickinger, Stefan
    Gabriel, Maximilian
    Graf, Alexandra
    Krepler, Katharina
    Ansari-Shahrezaei, Siamak
    JOURNAL OF OPHTHALMOLOGY, 2021, 2021
  • [26] Quantifying Changes on OCT in Eyes Receiving Treatment for Neovascular Age-Related Macular Degeneration
    Moraes, Gabriella
    Struyven, Robbert
    Wagner, Siegfried K.
    Liu, Timing
    Chong, David
    Abbas, Abdallah
    Chopra, Reena
    Patel, Praveen J.
    Balaskas, Konstantinos
    Keenan, Tiarnan D. L.
    Keane, Pearse A.
    OPHTHALMOLOGY SCIENCE, 2024, 4 (06):
  • [27] Optical coherence tomography angiography reproducibility of lesion size measurements in neovascular age-related macular degeneration (AMD)
    Amoroso, Francesca
    Miere, Alexandra
    Semoun, Oudy
    Jung, Camille
    Capuano, Vittorio
    Souied, Eric H.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2018, 102 (06) : 821 - 826
  • [28] Optical coherence tomography angiography in age-related macular degeneration: The game changer
    Lupidi, Marco
    Cerquaglia, Alessio
    Chhablani, Jay
    Fiore, Tito
    Singh, Sumit Randhir
    Piccolino, Felice Cardillo
    Corbucci, Roberta
    Coscas, Florence
    Coscas, Gabriel
    Cagini, Carlo
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2018, 28 (04) : 349 - 357
  • [29] The Incidence of Neovascular Subtypes in Newly Diagnosed Neovascular Age-Related Macular Degeneration
    Jung, Jesse J.
    Chen, Christine Y.
    Mrejen, Sarah
    Gallego-Pinazo, Roberto
    Xu, Luna
    Marsiglia, Marcela
    Boddu, Sucharita
    Freund, K. Bailey
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 158 (04) : 769 - 779
  • [30] Impact of optical coherence tomography angiography on the non-invasive diagnosis of neovascular age-related macular degeneration
    Giocanti-Auregan, Audrey
    Dubois, Lise
    Dourmad, Pauline
    Cohen, Salomon Y.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (03) : 537 - 541